A Case Study: Scientific Communications Support During Uncertain Times
Med Communications has many happy clients, and in our series of case studies, we’ll be talking about some of our long-term clients, the challenges we face alongside them, and how we help them be more efficient, increase the quality of their calls and documents, and use the efficiency and the scalability we offer to meet their budgetary needs.
This case study focuses on a small biopharmaceutical client whose product launch did not go as planned, and how the Med Communications team was able to pivot to support their changing needs.
Read our case study below for more information.
Scientific Communications Support During Uncertain Times
Med Communications’ responsiveness and flexibility allowed for unwavering and consistent support of a client during uncertain times. The client was able to scale services as needed while attending to urgent risk management and other business matters.
Background
Client: A small biopharmaceutical company needed support for the development and review of scientific communications deliverables during a product launch.
The launch phase of a product life cycle requires a fast-paced, dynamic environment involving multiple communications experts across different teams. These professionals work concurrently to execute countless deliverables over several months with targeted but fluid deadlines.
Challenge
With the expectation of FDA approval, pharmaceutical companies prepare for a flurry of activity leading up to PDUFA and throughout the product launch period. Significant amounts of time and money are invested in the development and review of scientific communications deliverables needed to support product launch. Despite all the preparation, many companies may receive a complete response letter from the FDA which often requires redirection of company strategy and rescaling of human capital.
Solution
To support the client effectively, Med Communications’ Scientific Communications team played pivotal roles in all the required activities related to scientific advisory, development, and review of medical and scientific information. The team was also heavily engaged in project management and training processes that involved the implementation of medical information (MI) asset management platforms, as well as development of a standard response letter database, slide decks, and congress materials. Our Scientific Communications team’s versatility, broad medical writing capabilities, and subject-matter expertise provided end-to-end support for MI content development activities. Med Communications provided a staff working model with teams of experts that allowed for proficiency, efficiency, and overall quality of MI deliverables.
As the client’s needs evolved during the pre-launch phase, our Scientific Communications team made adjustments to ensure all the client’s needs were met. After the client received a complete response letter from the FDA, Med Communications remained flexible, agile, and willing to pivot and scale to fit emerging needs. Our team continued to provide support even though the demand for MI assets substantially decreased in alignment with the client’s revised company strategy.
Business Impact
Med Communications provides flexibility and adaptability, as was evident in the team’s ability to rapidly pivot and scale while ensuring the delivery of high-quality MI content and services, despite unpredictable times. Our expertise in medical communications strategic consulting helped the client organize and optimize functional operations and overall MI management activities during the product launch period. Our client was empowered to establish a foundation of sustainability and success for the company’s MI organization, even during uncertain times.